Live Chat

Undisclosed Pradaxa Risk Attract FDA Attention and Lawsuits

The maker of Pradaxa, a popular anticoagulant used to treat a number of medical conditions including atrial fibrillation, is under scrutiny by the federal government, the media, and victims and their families in the wake of medical studies which suggest that some of the health risks associated with this product may be greater than reported.


Specifically, the FDA is currently investigating Pradaxa’s tendency to increase the risk of heart attacks and several victim lawsuits have pointed to medical research suggesting that internal bleeding may be a more serious problem than anticipated.


With health products, its important for drug manufacturers to fully, timely, and accurately communicate the risks of their products so that health care providers and patients have a complete picture of the risks and rewards of a particular treatment option. Sadly, it seems that Pradaxa may be an instance in which some patients were unnecessarily hurt as a result of an incomplete risk profile.


Want to know more about how the dedicated attorneys at Fears Nachawati may be able to help your loved one find justice in the wake of their Pradaxa injury? Our professionals are prepared to advise you. For your free consultation, call us at 1.866.545.8364 or email We’re ready to give you the help you need.

Drug Litigation Uncategorized

Undisclosed Pradaxa Risk Attract FDA Attention and Lawsuits